Palliative radiotherapy: New prognostic factors for patients with bone metastasis
Cancer/Radiothérapie · 2024
DOI: 10.1016/j.canrad.2023.09.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer/Radiothérapie, 2024. Verfasst von I N Steinvoort-Draat und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of radiotherapy, Erasmus MC Cancer Institute, Postbus 2040, 3000 CA Rotterdam, The Netherlands. Electronic address: i.draat@erasmusmc.nl. Hauptthemen laut MEDLINE: Bone Neoplasms, Palliative Care, Karnofsky Performance Status. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
PURPOSE: Many cancer patients develop bone metastases, however the prognosis of overall survival differs. To provide an optimal treatment for these patients, especially towards the end of life, a reliable prediction of survival is needed. The goal of this study was to find new clinical factors in relation to overall survival. MATERIALS AND METHODS: Prospectively 22 clinical factors were collected from 734 patients. The Kaplan-Meier and Cox regression models were used. RESULTS: Most patients were diagnosed with lung cancer (29%), followed by prostate (19.8%) and breast cancer (14.7%). Median overall survival was 6.4months. Fourteen clinical factors showed significance in the univariate analyses. In the multivariate analyses 6 factors were found to be significant for the overall survival: Karnofsky performance status, primary tumor, gender, total organs affected, morphine use and systemic treatment options after radiotherapy. CONCLUSION: Morphine use and systemic treatment options after radiotherapy, Karnofsky performance status, primary tumor, gender and total organs affected are strong prediction factors on overall survival after palliative radiotherapy in patients with bone metastasis. These factors are easily applicable in the clinic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of radiotherapy, Erasmus MC Cancer Institute, Postbus 2040, 3000 CA Rotterdam, The Netherlands. Electronic address: i.draat@erasmusmc.nl.
- Department of radiotherapy, Erasmus MC Cancer Institute, Postbus 2040, 3000 CA Rotterdam, The Netherlands.
Zitieren
APA
Steinvoort-Draat, I. N., Otto-Vollaard, L., Quint, S., Tims, J. L., de Pree, I. M. N., & Nuyttens, J. J. (2024). Palliative radiotherapy: New prognostic factors for patients with bone metastasis. Cancer/Radiothérapie. https://doi.org/10.1016/j.canrad.2023.09.003
Vancouver
Steinvoort-Draat IN, Otto-Vollaard L, Quint S, Tims JL, de Pree IMN, Nuyttens JJ. Palliative radiotherapy: New prognostic factors for patients with bone metastasis. Cancer/Radiothérapie. 2024. doi:10.1016/j.canrad.2023.09.003
BibTeX
@article{SteinvoortDraat2024,
author = {Steinvoort-Draat, I N and Otto-Vollaard, L and Quint, S and Tims, J L and de Pree, I M N and Nuyttens, J J},
title = {Palliative radiotherapy: New prognostic factors for patients with bone metastasis},
journal = {Cancer/Radiothérapie},
year = {2024},
doi = {10.1016/j.canrad.2023.09.003}
}
EUVIMED